BCL2 and carcinoma: Numerous reports have also suggested that the transcription factors nuclear factor‐kB (NF‐kB) and activator protein‐1 (AP‐1) can regulate the expression of Bcl‐2 leading to the transition of benign carcinomas towards malignant phenotype.29